ELF3 and cancer: Neither the Longoni study [19] nor the Shatnawi study [12] used normal or benign cells as comparison controls in the biological studies, and each study used different cancer cell models; thus, conclusions were that ELF3 might be a tumour suppressor or oncogene, or it may be context and cell‐dependent.